Sanofi anticipates profitable growth to continue over at least five years
Source: SeekingAlpha
2026-01-29 04:09:34 ET
More on Sanofi
- Sanofi (SAN:CA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Sanofi (SAN:CA) Discusses Year-End Late-Stage Pipeline Review With Focus on Clinical and Regulatory Developments Transcript
- Sanofi (SAN:CA) Discusses Year-End Late-Stage Pipeline Review With Focus on Clinical and Regulatory Developments - Slideshow
- Sanofi Non-GAAP EPS of €1.53 beats by €0.06, revenue of €11.3B beats by €170M; issues FY26 outlook
- Sanofi, Regeneron’s Dupixent approved in Japan for children with asthma
Read the full article on Seeking Alpha
For further details see:
Sanofi anticipates profitable growth to continue over at least five years
Banco Santander S.A. Sponsored ADR
NASDAQ: SAN
SAN Trading
-1.85% G/L:
$10.86 Last:
7,497,165 Volume:
$11.05 Open:
SAN Latest News
February 03, 2026 01:38:00 pm
Webster Financial Corporation Enters Into Merger Agreement With Banco Santander, S.A. for $12.3 Billion
SAN Stock Data
$212,542,521,684
14,572,031,202
2.7%
312
N/A
Banking
Finance
ES
Boadilla del Monte
